USPTO Defends Arthrex Review System To Fed. Circ.
The U.S. Patent and Trademark Office told the Federal Circuit on Wednesday that its interim director can review Patent Trial and Appeal Board decisions under a recent U.S. Supreme Court ruling,...To view the full article, register now.
Already a subscriber? Click here to view full article